afyaTECH Japan

afyaTECH Japan

From October 09, 2024 until October 11, 2024

Katika Yokohama - Pacifico Yokohama, Mkoa wa Kanagawa, Japani

Imetumwa na Canton Fair Net

[barua pepe inalindwa]

https://jcd-expo.jp/ja/


BioJapan / 再生医療JAPAN / healthTECH JAPAN

Wafadhili wa Platinamu 2023.

Sekretarieti ya BioJapan JTB Communication Design Co. Ltd. Jengo la Celestine Shiba Mitsui, 3-23-1 Shiba, Minato-ku, Tokyo 105-8335 barua pepe: [barua pepe inalindwa].

Kamati ya Maandalizi ya BioJapanJTB Communication Design Co. Ltd.

Sekretarieti ya Dawa za Kuzaliwa upya JAPANJTB Communication Design Co. Ltd. Jengo la Celestine Shiba Mitsui, 3-23-1 Shiba, Minato-ku, Tokyo 105-8335 barua pepe: [barua pepe inalindwa].

Jukwaa la General Incorporated Association Regenerative Medicine Innovation Association General Incorporated FoundationJTB Communication Design Co. Ltd.

healthTECH JAPAN SecretariatJTB Communication Design Co. Ltd. Celestine Shiba Mitsui Building, 3-23-1 Shiba, Minato-ku, Tokyo 105-8335 barua pepe: [barua pepe inalindwa].

Chama cha Bioindustry General Incorporated FoundationJTB Communication Design Co. Ltd.

Ni tukio kongwe zaidi la teknolojia ya kibayoteknolojia duniani, lililofanyika kwa mara ya kwanza mwaka wa 1986. Limekua kwa kasi tangu miaka ya 2000 na litafanyika mwaka wa 2023 kwa muda wa 25 mfululizo. Bayoteknolojia itatumika katika nyanja nyingi ikiwa ni pamoja na ugunduzi wa dawa na dawa za kibinafsi. Maonyesho, semina na programu za ushirikiano zinaweza kuharakisha uvumbuzi wazi katika bioindustry.Imefadhiliwa na Kamati ya Maandalizi ya BioJapanJTB Communication Design Co. Ltd.

Since the Nobel Prize in Physiology or Medicine was awarded to Professor Yamanaka from Kyoto University in 2012 and the creation of "Regenerative Medicine Related Laws", in 2014, the number of new entrants in the field of regenerative medicines has increased, not only in Japan, but also abroad. Research and practical application efforts are increasing.The research and development market of regenerative medical technologies has existed for many years, but the issue at the moment is that the number of products available in Japan is lower than those found in Western countries or South Korea.We hold global seminars, as well as conducting business negotiations with a functional match system, which is unique to an exhibition in Japan. We will accelerate industrialization and practical application ofSponsored by Regenerative Medicine Innovation Forum Bioindustry Association General Incorporated FoundationJTB Communication Design Co. Ltd.